P

Prime Medicine Inc
NASDAQ:PRME

Watchlist Manager
Prime Medicine Inc
NASDAQ:PRME
Watchlist
Price: 2.9 USD 3.94% Market Closed
Market Cap: 380.4m USD
Have any thoughts about
Prime Medicine Inc?
Write Note

Wall Street
Price Targets

PRME Price Targets Summary
Prime Medicine Inc

Wall Street analysts forecast PRME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRME is 12.75 USD with a low forecast of 5.05 USD and a high forecast of 19.95 USD.

Lowest
Price Target
5.05 USD
74% Upside
Average
Price Target
12.75 USD
340% Upside
Highest
Price Target
19.95 USD
588% Upside

PRME Last Price Targets
Prime Medicine Inc

The latest public price target was made on May 7, 2024 by Maury Raycroft from Jefferies , who expects PRME stock to rise by 417% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Maury Raycroft
Jefferies
15 USD
Upside 417%
7 months ago
May 7, 2024
Prime Medicine assumed with a Buy at Jefferies
TheFly
David Nierengarten
Wedbush
12 USD
Upside 314%
8 months ago
Apr 2, 2024
Prime Medicine initiated with a Buy at Wedbush
TheFly
Kostas Biliouris
BMO Capital
19 USD
Upside 555%
1 year ago
Oct 9, 2023
Preclinical-Phase Firm Prime Medicine's Gene Editing Platform Has Potential: Analyst
Benzinga
Maury Raycroft
Jefferies
Price Target 15 USD
Upside/Downside 417%
View Source
David Nierengarten
Wedbush
Price Target 12 USD
Upside/Downside 314%
View Source
Kostas Biliouris
BMO Capital
Price Target 19 USD
Upside/Downside 555%
View Source
Prime Medicine Inc Competitors:
Price Targets
DAWN
Day One Biopharmaceuticals Inc
195% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
28% Upside
2160
GNI Group Ltd
22% Upside
LGND
Ligand Pharmaceuticals Inc
11% Upside
4893
Noile-Immune Biotech Inc
181% Upside
ADAG
Adagene Inc
350% Upside
FYB
Formycon AG
80% Upside
ALRN
Aileron Therapeutics Inc
658% Upside

Revenue
Forecast

Revenue Estimate
Prime Medicine Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Prime Medicine Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Prime Medicine Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRME's stock price target?
Price Target
12.75 USD

According to Wall Street analysts, the average 1-year price target for PRME is 12.75 USD with a low forecast of 5.05 USD and a high forecast of 19.95 USD.

Back to Top